A recent investigation by the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) has highlighted significant disparities in how Medicare Advantage Organizations (MAOs) manage prior authorization requests for post-acute care. The report reveals that the largest Medicare Advantage plans deny requests for inpatient rehabilitation facilities (IRFs) and long-term care hospitals (LTCHs) at higher rates than smaller organizations, a trend that is increasingly shifting the burden of patient care onto home health providers. According to the OIG’s findings, these denials often force hospitals to seek alternative discharge pathways, frequently resulting in patients with higher clinical acuity being transitioned into home-based care settings.
For home health agencies, this shift creates a complex operational environment. When a patient is denied access to an IRF or LTCH—facilities typically equipped for intensive recovery—they may be discharged directly to home care with significant, unresolved medical needs. As noted in the OIG report on Medicare Advantage prior authorization denials, the reversal rates for these initial denials—reaching 36% for LTCHs and 43% for IRFs—suggest that many beneficiaries were initially denied services that were later deemed medically necessary. This creates a “bottleneck” effect where home health providers must manage patients who would have otherwise received specialized inpatient care.
The Impact of Denial Patterns on Home Health Acuity
The administrative burden of prior authorization is not merely a logistical challenge; it is a clinical one. When insurers deny access to higher-level post-acute settings, the patient’s health trajectory is often redirected toward home health, regardless of whether the home environment is equipped for such complexity. Data from the Centers for Medicare & Medicaid Services (CMS) indicates that the enrollment in Medicare Advantage has grown significantly, placing more patients under these specific authorization requirements. For clinicians, this means accepting patients with a higher risk of readmission, requiring more intensive nursing visits, and demanding tighter coordination with hospital discharge planners on compressed timelines.
The variation in denial rates among plans is striking. The OIG report noted that IRF overturn rates ranged from 14% to 86% across different plans, a disparity that complicates the referral process for hospital social workers and discharge planners. When a hospital faces a denial from an MAO, they must pivot quickly to avoid extended hospital stays, often opting for home health as the path of least resistance. This forces home health agencies to scale up clinical staffing for complex cases without necessarily receiving a corresponding increase in reimbursement, as fee-for-service models remain distinct from the negotiated rates often found in Medicare Advantage contracts.
Operational Challenges for Providers
Home health providers are currently navigating a landscape where Medicare Advantage is the dominant payer, yet it is also the source of significant friction. Industry surveys consistently cite prior authorization delays and administrative denials as primary stressors. These barriers to care do more than delay treatment; they disrupt the continuity of care. According to the OIG’s broader review of Medicare Advantage, the systematic nature of these denials can lead to delayed medical treatment, which in turn increases the likelihood of emergency department visits for home-bound patients.
The financial sustainability of this model remains a point of contention. While providers are expected to manage higher-acuity patients, the reimbursement structures often do not account for the increased operational risk. The OIG report underscores that when patients do not appeal their denials, they may be forced to pay out of pocket or go without necessary post-acute services entirely. For home health agencies, this means that even when they do accept the patient, they are often managing cases that are technically beyond the scope of traditional home-based recovery, leading to higher rates of nurse burnout and increased administrative oversight.
What Happens Next for Medicare Advantage Oversight
In response to these findings, the OIG has recommended that CMS implement more rigorous oversight of request-level prior authorization data. By collecting information on service types and specific contractor denials, regulators aim to better understand why certain organizations demonstrate outlier behavior in their denial and overturn rates. CMS has indicated a commitment to monitoring these trends, though the timeline for new, nationwide reporting requirements remains under development. For now, providers are encouraged to monitor their own patient data to identify trends in denial rates by specific payers.
Moving forward, the industry is closely watching for updates from CMS regarding potential policy changes that could mandate greater transparency in how MAOs issue denials. Any future rulemaking will likely focus on standardizing the criteria for medical necessity to ensure that patients are not inappropriately diverted from IRFs or LTCHs. Until such standards are enforced, home health agencies will likely continue to absorb the clinical and financial consequences of upstream authorization failures. Stakeholders are encouraged to participate in upcoming CMS listening sessions and industry policy forums to ensure the provider perspective is represented as these oversight mechanisms evolve.